Differential modulation of μ- and δ-opioid antinociception by neuropeptide FF receptors in young mice

Neuropeptides

Volumn 31, Issue 1, 1997, Pages 1-7

  Desprat, C ^a   Zajac, J M ^a  

^a INSTITUT DE PHARMACOLOGIE ET DE BIOLOGIE STRUCTURALE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DELTA OPIATE RECEPTOR; DELTORPHIN DERIVATIVE; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; MU OPIATE RECEPTOR; NALTREXONE; NALTRINDOLE; NEUROPEPTIDE FF; NEUROPEPTIDE FF DERIVATIVE; OPIATE AGONIST; UNCLASSIFIED DRUG;

ADOLESCENT; ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; BEHAVIOR; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA;

EID: 0031058299     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-4179(97)90010-X     Document Type: Article

References (30)

1. Yang H-Y T, Fratta W, Majane E A, Costa E. Isolation, sequencing, synthesis, and pharmacological characterization of the two brain neuropeptides that modulate the action of morphine. Proc Natl Acad Sci 1985; 82: 7757-7761.
2. Majane E A, Casanova M F, Yang H-Y T. Biochemical characterization of FMRFNH2-like peptide in spinal cord of various mammalian species using specific radioimmunoassays. Peptides 1988; 9: 1137-1144.
3. Gicquel S, Mazarguil H, Allard M, Simonnet G, Zajac J-M. Analogues of F8Famide resistant to degradation, with high affinity and in vivo effects. Eur J Pharmacol 1992; 222: 61-67
4. Oberling P, Stinus L, Moal M L, Simonnet G. Biphasic effect on nociception and antiopiate activity of neuropeptide FF (FLFQPQRFamide) in the rat. Peptides 1993; 14: 919-924.
5. Kavaliers M, Yang H-Y T. IgG from antiserum against endogenous mammalian FMRF-NH2-related peptides augments morphine-and stress-induced analgesia in mice. Peptides 1989; 10: 741-745.
6. Malin D H, Lake J R, Hammond M V et al. FMRF-NH2-like mammalian octapeptide: possible role in opiate dependence and abstinence. Peptides 1990; 11: 969-972.
7. Allard M, Zajac J-M, Simonnet G. Autoradiographic distribution of receptors to FLFQPQRFamide, a morphine-modulating peptide, in rat central nervous system. Neuroscience 1992; 49: 101-116.
8. Allard M, Geoffre S, Legendre P, Vincent J D, Simonnet G. Characterization of rat spinal cord receptors to FLFQPQRFamide, a mammalian morphine modulating peptide: a binding study. Brain Res 1989; 500: 169-176.
9. Allard M, Jordan D, Zajac J-M et al. Autoradiographic localization of receptors for neuropeptide FF, FLFQPQRFamide, in human spinal sensory system. Brain Res 1994; 633: 132-137
10. Gouardères C, Sutak M, Zajac J-M, Jhamandas K. Antinociceptive effects of intrathecally administered F8Famide and FMRFamide in the rat. Eur J Pharmacol 1993; 237: 73-81.
11. Gicquel S, Fioramonti J, Bueno L, Zajac J-M. Effects of F8Famide analogs on intestinal transit in mice. Peptides 1993; 14: 749-753.
12. Millon M, Fioramonti J, Gicquel S, Zajac J-M, Bueno L. Comparative action of Phe-Leu-Phe-Gln-Pro-Gln-Arg-Phe-NH2 analogs on intestinal motility and nociception in rats. J Pharmacol Exp Ther 1993; 265: 96-102.
13. Desprat C, Roumy M, Zajac J-M. Neuromodulatory effects of neuropeptide FF on opioid functions in mice. Regul Pept 1994; 54: 81-82.
14. Desprat C, Zajac J-M. Ontogeny of neuropeptide FF pharmacology and receptors in mouse brain. Dev Brain Res 1994; 82: 118-126.
15. Haley T J, McCormick W G. Pharmacological effects produced by intra-cerebral injection of drugs in conscious mouse. Br J Pharmacol 1957; 12: 12-15.
16. Devillers J-P, Labrouche S A, Castes E, Simonnet G. Glutamate via NMDA receptors promotes the release of NPFF, an antiopioid peptide, from rat spinal cord slices. Regul Pept 1994; 54: 85-86.
17. Mokhtari M, Tafani J-A M, Zajac J-M. Binding in vivo of selective μ and δ opioid agonists: localization by autoradiography. Neuropeptides 1993; 25: 183-191.
18. Fang F G, Fields H L, Lee N M. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates. J Pharmacol Exp Ther 1986; 238: 1039-1044.
19. Dauge V, Petit F, Rossignol P, Roques B P. Use of μ and δ opioid peptides of various selectivity gives further evidence of specific involvement of μ opioid receptors in supraspinal analgesia (tailflick test). Eur J Pharmacol 1987; 141: 171-178.
20. Meucci E, Delay-Goyet P, Roques B, Zajac J-M. Binding in vivo of selective μ and δ opioid agonists: opioid receptors occupancy by endogenous enkephalins. Eur J Pharmacol 1989; 171: 167-178.
21. Chaillet P, Coulaud A, Zajac J-M, Fournié-Zaluski M-C, Costentin J, Roques B P. The μ rather than the δ subtype of opioid receptors appears to be involved in enkephalin-induced analgesia. Eur J Pharmacol 1984; 101: 83-90.
22. Porreca F, Mosberg H I, Hurst R, Hruby V J, Burks T F. Role of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse. J Pharmacol Exp Ther 1984; 230: 341-348.
23. Blisky EJ, Bernstein R N, Pasternak G W et al. Selective inhibition of [D-Ala2,Glu4]deltorphin antinociception by supraspinal, but not spinal, administration of an antisense oligodeoxynucleotide to an opioid delta receptor. Life Sci 1994; 55: 37-43.
24. Garzon J, Castro M A, Juarros J L, Sanchez-Blazquez P. Antibodies raised against the N-terminal sequence of δ opioid receptors blocked δ-mediated supraspinal antinociception in mice. Life Sci 1994; 54: 191-196.
25. Portoghese P S, Sultana M, Takemori A E. Naltrindole, a highly selective and potent non-peptide δ opioid receptor antagonist. Eur J Pharmacol 1988; 146: 185-186.
26. Shah S, Davis T, Yoburn B C. The effect of naltrindole on spinal and supraspinal delta opioid receptors and analgesia. Life Sci 1994; 55: 1451-1458.
27. Jackson H C, Ripley T L, Nutt D J. Exploring δ-receptor function using the selective opioid antagonist naltrindole. Neuropharmacology 1989; 28: 1427-1430.
28. Jiang Q, Takemori A E, Sultana M et al. Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5′-isothiocyanate: evidence for delta receptor subtypes. J Pharmacol Exp Ther 1991; 257: 1069-1075.
29. Magnuson D S K , Sullivan A F, Simonnet G, Roques B P, Dickenson A H. Differential interactions of cholecystokinin and FLFQPQRF-NH2 with μ and δ opioid antinociception in the rat spinal cord. Neuropeptides 1990; 16: 213-218.
30. McDowell J, Kitchen I. Development of opioid systems: peptides, receptors and pharmacology. Brain Res Rev 1987; 12: 397-421.